首页> 外国专利> METHOD OF DIAGNOSING, CLASSIFYING AND TREATING ENDOMETRIAL CANCER AND PRECANCER USING MUTATIONS IN FIBROBLAST GROWTH FACTOR RECEPTOR 2 (FGFR2)

METHOD OF DIAGNOSING, CLASSIFYING AND TREATING ENDOMETRIAL CANCER AND PRECANCER USING MUTATIONS IN FIBROBLAST GROWTH FACTOR RECEPTOR 2 (FGFR2)

机译:使用成纤维细胞生长因子受体2(FGFR2)突变诊断,分类和治疗子宫内膜癌及前体癌的方法

摘要

Diagnostic and therapeutic applications for endometrial cancer are described. The diagnostic and therapeutic applications are based on certain activation mutations in the FGFR2 gene and its expression products. The present invention is directed to nucleotide sequences, amino acid sequences, probes, and primers related to FGFR2 activation mutants and kits comprising these mutants to diagnosis and classify endometrial cancer in a subject.
机译:描述了子宫内膜癌的诊断和治疗应用。诊断和治疗应用基于FGFR2基因及其表达产物中的某些激活突变。本发明涉及与FGFR2活化突变体有关的核苷酸序列,氨基酸序列,探针和引物,以及包含这些突变体的试剂盒,以在受试者中诊断和分类子宫内膜癌。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号